Postneoadjuvant Therapy clinical trials at UCSF

1 research study open to eligible people

Postneoadjuvant therapy refers to treatment given after primary therapy to manage cancer. UCSF is researching how radiation therapy works for gastrointestinal cancers that have spread to other parts of the body. These trials help in discovering better cancer treatment options.

Showing trials for

  • Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers

    open to eligible people ages 18 years and up

    This phase II trial studies how well radiation therapy works for the treatment of gastrointestinal cancer that are spreading to other places in the body (metastatic). Radiation therapy uses high energy x-rays to kill cancer cells and shrink tumors. This trial is being done to determine if giving radiation therapy to patients who are being treated with immunotherapy and whose cancers are progressing (getting worse) can slow or stop the growth of their cancers. It may also help researchers determine if giving radiation therapy to one tumor can stimulate the immune system to attack other tumors in the body that are not targeted by the radiation therapy.

    San Francisco, California

Our lead scientists for Postneoadjuvant Therapy research studies include .

Last updated: